PHARVARIS

Serial Number 99181024
681

Registration Progress

Application Filed
May 12, 2025
Under Examination
Approved for Publication
Published for Opposition
Nov 11, 2025
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Dec 26, 2025 53 days

Trademark Image

PHARVARIS

Basic Information

Serial Number
99181024
Filing Date
May 12, 2025
Published for Opposition
November 11, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Oct 23, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Pharvaris GmbH

99
Address
Grafenauweg 8
Zug 6300
CH

Ownership History

Pharvaris GmbH

Original Applicant
99
Zug CH

Legal Representation

Attorney
Makiko Coffland

USPTO Deadlines

Next Deadline
53 days remaining
Non-Final Action Mailed
Due Date
December 26, 2025
Extension Available
Until March 26, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Oct 15, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 14, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 26, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 26, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 21, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 12, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 12, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of rare and orphan inflammatory, allergic and immunological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hematological diseases and disorders; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for the treatment and prevention of genetic inflammatory, allergic, and immunological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hereditary angioedema (HAE); pharmaceutical preparations for the treatment and prevention of bradykinin mediated angioedema; pharmaceutical preparations for the treatment and prevention of acquired angioedema
Class 042
Providing medical and scientific research information
Class 044
Providing medical information; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Classification

International Classes
005 042 044